• Insane Ambition
  • Posts
  • 🎙️Harry Al-Wassiti: Bioengineering and the Future of mRNA-based Therapies

🎙️Harry Al-Wassiti: Bioengineering and the Future of mRNA-based Therapies

In Today’s Email:

  • Insane Ambition Episode #5

  • A Sneak-Peek into Episode #6

Orange Podcast Episode #5

🎙️Harry Al-Wassiti: Bioengineering and the Future of mRNA-based Therapies 

Harry Al-Wassiti is a visionary bioengineer. More than 14 years after leaving war-torn Iraq, he spearheads Australia's mRNA therapeutic program. 

Harry believed in mRNA therapeutics well before they became mainstream via the Pfizer and Moderna vaccines. In 2019, he published a Medium article advocating for mRNA-based therapeutics just months before the COVID-19 pandemic. 

But new medicines are useless without the ability to build them affordably and at scale.

There is this essential marriage of innovation and manufacturing, “We’re developing amazing medicines, but their deployment hinges on solving manufacturing issues.”

For a country that too often outsources its most complex manufacturing processes to China and the US, we need someone like Harry in Australia to be thinking about the machine that builds the machine. After all, having mRNA manufacturing facilities within our borders is a national security issue.

Stay up to speed on our episodes by following us on LinkedIn and X (Twitter).

A Sneak-Peek into Episode #6

🎙️Hunter Watkin: Venture Capital, Investment, and Startups in Emerging Technologies

Venture capital may sound glamorous, but as Hunter Watkin knows, "statistically, the vast majority of startups will fail.” So how does Hunter, a VC at Rampersand, identify the unicorns among the litany of early-stage startups that slide into his email inbox?

For Hunter, being a VC is about much more than just getting a high ROI. It's about empowering wildly ambitious founders to build the future.

Be sure to catch it on Spotify, Apple Podcasts and YouTube!